Trade Secret Litigation Review: How is Major Case Law Affecting Your Strategy? | Kisaco Research

Trade secret litigation can be costly and is only rising with a greater awareness of the opportunities to protect your innovation with trade secret law. This expert panel session will review the latest cases and provide you with insights on how to successfully implement a trade secret litigation strategy.

Brian Walters, Executive Vice President and General Counsel, Matthews International
Chuck Sholtz, Vice President Intellectual Property, Nutcracker Therapeutics

Speaker(s): 

Author:

Brian Walters

Executive Vice President and General Counsel
Matthews International

Brian D. Walters serves as Executive Vice-President and General Counsel for Matthews International Corporation, Pittsburgh’s oldest company in continuous operation since 1850 and operating in over 25 countries with over 12,000 employees.  During his 18-year tenure at Matthews, the Company has more than tripled in annual revenue, now producing approximately $1.8 billion in sales.   Brian has directed all legal matters for this publicly-traded corporation both nationally and internationally, as well as serving as a member of Matthews’ executive leadership team.  Mr. Walters has led over 75 domestic and foreign acquisition initiatives at Matthews, including extensive experience coordinating strategies to secure transaction approval from the U.S. Federal Trade Commission, managing HSR filings, as well as filings with the competition authority of the European Union.

Brian Walters

Executive Vice President and General Counsel
Matthews International

Brian D. Walters serves as Executive Vice-President and General Counsel for Matthews International Corporation, Pittsburgh’s oldest company in continuous operation since 1850 and operating in over 25 countries with over 12,000 employees.  During his 18-year tenure at Matthews, the Company has more than tripled in annual revenue, now producing approximately $1.8 billion in sales.   Brian has directed all legal matters for this publicly-traded corporation both nationally and internationally, as well as serving as a member of Matthews’ executive leadership team.  Mr. Walters has led over 75 domestic and foreign acquisition initiatives at Matthews, including extensive experience coordinating strategies to secure transaction approval from the U.S. Federal Trade Commission, managing HSR filings, as well as filings with the competition authority of the European Union.

Author:

Chuck Sholtz

Vice President Intellectual Property
Nutcracker Therapeutics

Chuck Sholtz

Vice President Intellectual Property
Nutcracker Therapeutics